Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

6082 ARTÍCULOS , VIENDO DEL 5761 AL 5775

Transforming Care Across Countries: Lessons from the Integrated Care Networks for Parkinson's Disease Study (iCARE-PD)

Dash D, Fabbri M, Saade J, van Munster M, Pedrosa D, Růžička E, Gal O, Ferreira JJ, Sánchez-Ferro Á, Lynch T, Eggers C, Singh A, Grimes D, Taljaard M, Rascol O, Mestre TA; and the iCARE‐PD consortium.

Mov Disord. 2026 Feb;41(2):445-454. doi: 10.1002/mds.70110. Epub 2025 Nov 27.

Aging immunity - the role of T and B cells in neurological disorders among older adults

Kwinta R, Morawiec N, Bączyk J, Kubicka-Bączyk K, Adamczyk-Sowa M.

Neurol Neurochir Pol. 2026;60(1):15-25. doi: 10.5603/pjnns.106498. Epub 2025 Nov 28.

Evaluation and management of male sexual dysfunction in Parkinson's disease: A clinical road map

Rafetto AN, Murray GR, Ziegelmann MJ.

J Parkinsons Dis. 2026 Feb;16(1):36-50. doi: 10.1177/1877718X251394341. Epub 2025 Nov 28.

EEG-based stratification in Alzheimer's disease: Cognitive progression, pathological marker associations, and therapeutic interventions

Pei Z, Zhu L, Ren H, Liu Y, Shi X, Lin Y, Wang J, Li P, Wang P, Ji Y, Zhou Y, Tang X, Jiang X, Tong X, Guo Y.

Clin Neurophysiol. 2026 Jan;182:2111440. doi: 10.1016/j.clinph.2025.2111440. Epub 2025 Nov 15.

Effect on Dyskinesia of the Early Combination of Amantadine to Levodopa-Therapy in Parkinson's Disease: A Randomized, Placebo-Controlled Study (PREMANDYSK)

Rascol O, Ory-Magne F, Meissner WG, Maltête D, Defebvre L, Azulay JP, Thobois S, Houeto JL, Thalamas C, Sommet A, Geny C, Damier P, Anheim M, Marquès A, Viallet F, Giroud M, Lefaucheur R, Costentin G, Spampinato U, Samier-Foubert A, Carrière N, Mutez E, Mariani LL, Eusebio A, Prange S, Benatru I, Charif M, Brefel-Courbon C, Fabbri M, Galitzky M, Rousseau V, Saubion A, Catala H, Ferreira JJ, Burn DJ, Corvol JC; PREMANDYSK Study Group.

Mov Disord. 2026 Mar;41(3):729-740. doi: 10.1002/mds.70120. Epub 2025 Nov 29.

'What's in a Name?' Naming Genetically Determined Movement Disorders: Gap and Controversy

Marras C, Albanese A, Hallett M, Klein C, Lohmann K; Genetic Nomenclature in Movement Disorders Study Group Steering Committee; Jinnah HA.

Mov Disord. 2026 Feb;41(2):342-350. doi: 10.1002/mds.70143. Epub 2025 Nov 29.

Cerebrospinal Fluid Biomarkers of NLRP3 Pathway, Immune Dysregulation, and Neurodegeneration in Parkinson's Disease: A Meta-Analysis

Marinescu AM, Machado V, Pagano G, Muelhardt NM, Kustermann T, Mracsko EZ, Brockmann K, Shariati N, Anzures-Cabrera J, Zinnhardt B.

Mov Disord. 2026 Feb;41(2):466-477. doi: 10.1002/mds.70103. Epub 2025 Nov 29.

Retinal structural changes in Parkinson's disease: differences in pRNFL thickness between GBA1-associated and idiopathic cases

Portaro G, Giacomelli M, Grisanti S, Taruffi L, Di Rauso G, Fioravanti V, Salomone G, Argenziano G, Sabadini R, Toschi G, Iotti O, Campanini I, Merlo A, Cavazzuti L, Damiano B, Scaltriti S, Scaglioni A, Paul JJ, Bauer P, Biagini G, Monfrini E, Di Fonzo A, Montepietra S, Valzania F, Vecchi M, Cavallieri F; FABIP-PD STUDY-GROUP.

Parkinsonism Relat Disord. 2026 Jan;142:108134. doi: 10.1016/j.parkreldis.2025.108134. Epub 2025 Nov 26.

Effects of Transcranial Pulse Stimulation (TPS) as a potential "add-on" intervention in patients with Parkinson's disease

Manganotti P, Liccari M, Lombardo TMI, Della Toffola J, Cenacchi V, Ajčević M, Catalan M, Busan P.

Parkinsonism Relat Disord. 2026 Jan;142:108128. doi: 10.1016/j.parkreldis.2025.108128. Epub 2025 Nov 24.

Advances in neurological therapies: A review of clinical trials in Alzheimer's, Parkinson's, and multiple sclerosis

de Souza PC, Bezerra TPW, de Melo Rêgo MJB, da Rosa MM.

Am J Med. 2026 Mar;139(3):264-275. doi: 10.1016/j.amjmed.2025.11.025. Epub 2025 Nov 27.

Assessment of myocardial sympathetic innervation with [(123)I]mIBG myocardial scintigraphy: A comparative study between an Anger and a ring-configured cadmium-zinc-telluride gamma camera

Hagerman J, Engblom SA, Andelius IC, Stenvall A, Minarik D, Hall S, Stomrud E, Nahimi A, Smith R, Hansson O, Hedeer F.

J Nucl Cardiol. 2026 Feb;56:102574. doi: 10.1016/j.nuclcard.2025.102574. Epub 2025 Nov 27.

Reduced distress tolerance and elevated depression in functional tremor: A comparative cross-sectional observational study of tremor disorders

Sheehan P, Deng Y, Phelps HE, Jasinski N, Pyle K, Coleman MM, Sblendorio D, Talkington D, Murray A, Memon AA, Moreno-Escobar MC, Frey J.

J Psychosom Res. 2026 Feb;201:112479. doi: 10.1016/j.jpsychores.2025.112479. Epub 2025 Nov 29.

Parkinsonism in people with virally suppressed HIV

Shorer EF, Dastgheyb RM, Rubin LH, Safonova A, Masters MC, Zaikos TD, Marais S, Robinson-Papp J.

Lancet HIV. 2026 Mar;13(3):e194-e206. doi: 10.1016/S2352-3018(25)00262-0. Epub 2025 Nov 29.

Factors impacting caregiver burden in Parkinson's disease: A systematic review and meta-analysis

Sin WWF, Chan LML, Ng CTY, Choi EPH, Lok KYW, Fong DYT, Kwok JYY.

Int J Nurs Stud. 2026 Feb;174:105299. doi: 10.1016/j.ijnurstu.2025.105299. Epub 2025 Nov 19.

Roles in physiology and disease of the inositol phosphatase synaptojanin 1

De Camilli P.

Biochim Biophys Acta Mol Cell Biol Lipids. 2026 Mar;1871(2):159708. doi: 10.1016/j.bbalip.2025.159708. Epub 2025 Nov 30.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias